These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10430630)

  • 1. The majority of H2-M3 is retained intracellularly in a peptide-receptive state and traffics to the cell surface in the presence of N-formylated peptides.
    Chiu NM; Chun T; Fay M; Mandal M; Wang CR
    J Exp Med; 1999 Aug; 190(3):423-34. PubMed ID: 10430630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional roles of TAP and tapasin in the assembly of M3-N-formylated peptide complexes.
    Chun T; Grandea AG; Lybarger L; Forman J; Van Kaer L; Wang CR
    J Immunol; 2001 Aug; 167(3):1507-14. PubMed ID: 11466371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogenous peptides enter the endoplasmic reticulum of TAP-deficient cells and induce the maturation of nascent MHC class I molecules.
    Levitt JM; Howell DD; Rodgers JR; Rich RR
    Eur J Immunol; 2001 Apr; 31(4):1181-90. PubMed ID: 11298343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The alloreactive T cell response against the class Ib molecule H2-M3 is specific for high affinity peptides.
    Dabhi VM; Hovik R; Van Kaer L; Lindahl KF
    J Immunol; 1998 Nov; 161(10):5171-8. PubMed ID: 9820487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tapasin enhances peptide-induced expression of H2-M3 molecules, but is not required for the retention of open conformers.
    Lybarger L; Yu YY; Chun T; Wang CR; Grandea AG; Van Kaer L; Hansen TH
    J Immunol; 2001 Aug; 167(4):2097-105. PubMed ID: 11489993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation.
    Luft T; Rizkalla M; Tai TY; Chen Q; MacFarlan RI; Davis ID; Maraskovsky E; Cebon J
    J Immunol; 2001 Sep; 167(5):2529-37. PubMed ID: 11509592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis.
    Chun T; Serbina NV; Nolt D; Wang B; Chiu NM; Flynn JL; Wang CR
    J Exp Med; 2001 May; 193(10):1213-20. PubMed ID: 11369792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens.
    Song R; Porgador A; Harding CV
    Immunology; 1999 Jun; 97(2):316-24. PubMed ID: 10447748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3.
    Wang CR; Castaño AR; Peterson PA; Slaughter C; Lindahl KF; Deisenhofer J
    Cell; 1995 Aug; 82(4):655-64. PubMed ID: 7664344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide affinity and concentration affect the sensitivity of M3-restricted CTLs induced in vitro.
    Byers DE; Lindahl KF
    J Immunol; 1999 Sep; 163(6):3022-8. PubMed ID: 10477565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selection of M3-restricted T cells is dependent on M3 expression and presentation of N-formylated peptides in the thymus.
    Chiu NM; Wang B; Kerksiek KM; Kurlander R; Pamer EG; Wang CR
    J Exp Med; 1999 Dec; 190(12):1869-78. PubMed ID: 10601361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP.
    Lewis JW; Neisig A; Neefjes J; Elliott T
    Curr Biol; 1996 Jul; 6(7):873-83. PubMed ID: 8805302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable immunodominance hierarchies for H2-M3-restricted N-formyl peptides following bacterial infection.
    Kerksiek KM; Busch DH; Pamer EG
    J Immunol; 2001 Jan; 166(2):1132-40. PubMed ID: 11145694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins.
    Tiwari N; Garbi N; Reinheckel T; Moldenhauer G; Hämmerling GJ; Momburg F
    J Immunol; 2007 Jun; 178(12):7932-42. PubMed ID: 17548631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.
    Bai A; Forman J
    J Immunol; 1997 Sep; 159(5):2139-46. PubMed ID: 9278300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive selection of an H2-M3 restricted T cell receptor.
    Berg RE; Princiotta MF; Irion S; Moticka JA; Dahl KR; Staerz UD
    Immunity; 1999 Jul; 11(1):33-43. PubMed ID: 10435577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ T cell protective immunity against Chlamydia pneumoniae includes an H2-M3-restricted response that is largely CD4+ T cell-independent.
    Tvinnereim A; Wizel B
    J Immunol; 2007 Sep; 179(6):3947-57. PubMed ID: 17785832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partially TAP-independent protection against Listeria monocytogenes by H2-M3-restricted CD8+ T cells.
    Rolph MS; Kaufmann SH
    J Immunol; 2000 Oct; 165(8):4575-80. PubMed ID: 11035099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
    Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
    J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern.
    Wainwright SD; Biro PA; Holmes CH
    J Immunol; 2000 Jan; 164(1):319-28. PubMed ID: 10605026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.